Hwang Kyoung-Yeon, Yoon Young-In, Hwang Shin, Ha Tae-Yong, Ahn Chul-Soo, Kim Ki-Hun, Moon Deok-Bog, Song Gi-Won, Jung Dong-Hwan, Lee Young-Joo, Park Kwang-Min, Lee Sung-Gyu
Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Korean J Hepatobiliary Pancreat Surg. 2015 Feb;19(1):11-6. doi: 10.14701/kjhbps.2015.19.1.11. Epub 2015 Feb 28.
BACKGROUNDS/AIMS: According to 7th AJCC TNM staging system, gallbladder carcinoma (GBC) with lymph node (LN) metastasis is classified as N1 or N2; thus making the stage IIIB (N1) or IVB (N2). Stage IIIB consists of N1 status with wide coverage of T1-3, but T3N1 group often showed poorer outcomes than T1-2N1 groups. This study intended to assess post-resection prognosis of T3N1 versus other stage III subgroups.
We selected 103 patients from our institutional database of GBC who underwent R0 resection between July 1996 and June 2009 and whose GBC was confined to stage T3N0, T1-3N1 or T1-3N2. These patients were stratified into five groups, namely, T3N0 (n=26), T1N1 (n=13), T2N1 (n=35), T3N1 (n=20) and T1-3N2 (n=9), and were followed for ≥5 years or until death.
Surgical procedures were minor liver resection (n=53), minor liver resection with bile duct resection (n=23), major liver resection (n=12), major liver resection with bile duct resection (n=5), and hepatopancreatoduodenectomy (n=12). Mean follow-up period was 57.2±68.5 months. Overall 5-year survival rate based on all-cause death and cancer-associated death, respectively, was 57.7% and 60.6% in T3N0, 15.4% and 15.4% in T1N1 (n=13), 28.6% and 28.6% in T2N1 (n=35), 5.0% and 5.7% in T3N1 (n=20), and 22.2% and 22.2% in T1-3N2. The survival outcome of T3N1 group was the poorest among the four stage III groups and was comparable to that of stage IVB (p=0.53).
The prognosis of T3N1 GBC is unusually poor even after R0 resection, thus we suggest extensive LN dissection may be necessary in patients with T3 tumors for accurate prognostic evaluation and radical removal of potential nodal micrometastasis. Further validation of this result is necessary in large patient populations from multiple centers.
背景/目的:根据美国癌症联合委员会(AJCC)第7版TNM分期系统,发生淋巴结(LN)转移的胆囊癌(GBC)被归类为N1或N2;因此属于ⅢB期(N1)或ⅣB期(N2)。ⅢB期包括N1状态且T1 - 3广泛受累,但T3N1组的预后通常比T1 - 2N1组差。本研究旨在评估T3N1与其他Ⅲ期亚组切除术后的预后。
我们从机构GBC数据库中选取了103例患者,这些患者在1996年7月至2009年6月期间接受了R0切除,且GBC局限于T3N0、T1 - 3N1或T1 - 3N2期。这些患者被分为五组,即T3N0(n = 26)、T1N1(n = 13)、T2N1(n = 35)、T3N1(n = 20)和T1 - 3N2(n = 9),并随访≥5年或直至死亡。
手术方式包括小范围肝切除(n = 53)、小范围肝切除联合胆管切除(n = 23)、大范围肝切除(n = 12)、大范围肝切除联合胆管切除(n = 5)以及胰十二指肠切除术(n = 12)。平均随访时间为57.2±68.5个月。基于全因死亡和癌症相关死亡的总体5年生存率,T3N0组分别为57.7%和60.6%,T1N1组(n = 13)为15.4%和15.4%,T2N1组(n = 35)为28.6%和28.6%,T3N1组(n = 20)为5.0%和5.7%,T1 - 3N2组为22.2%和22.2%。T3N1组的生存结果在四个Ⅲ期组中最差,与ⅣB期相当(p = 0.53)。
即使在R0切除术后,T3N1 GBC的预后仍异常差,因此我们建议对于T3期肿瘤患者,可能需要进行广泛的淋巴结清扫,以进行准确的预后评估并彻底清除潜在的淋巴结微转移。需要在多个中心的大量患者中进一步验证该结果。